The innate and adaptive immune systems play a fundamental role in combating microbial pathogens, as well as in targeting tumor cells. A critical component is presentation of foreign and self antigens for immune surveillance by the MHC family of cell surface glycoproteins. This proposal aims to characterize antigen loading and presentation by MHC and MHC-like molecules primarily through three-dimensional structure determination using x-ray crystallography. Our focus will be to elucidate: 1) Structural basis of lipid antigen presentation by the CD1 family to T cells through structure determination of CD1/antigen and CD1/TCR complexes. 2) Structural mechanism of antigen loading onto MHC class I by the membrane-bound peptide loading complex (PLC). A combined structural and biochemical approach using primarily high resolution x-ray crystallography will be used to characterize separate components and complexes of the peptide loading complex to identify important interactions within the PLC. These studies will provide structural models and functional insights into the exciting field of antigen loading, presentation, and restriction that will be useful in the design of novel therapeutics to combat microbial pathogens and cancer.

Public Health Relevance

MHC and MHC-like molecules in the immune system present antigens to T cells to enable detection and elimination of microbial pathogens, as well as tumor cells. We will investigate mechanisms of antigen presentation, loading and recognition using structural, biophysical and immunological methods. Such information can uncover strategies to combat and prevent microbial infections, fight certain cancers and aid in design of immunological therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA058896-17
Application #
7846898
Study Section
Macromolecular Structure and Function C Study Section (MSFC)
Program Officer
Knowlton, John R
Project Start
1994-01-01
Project End
2011-10-30
Budget Start
2010-05-01
Budget End
2011-10-30
Support Year
17
Fiscal Year
2010
Total Cost
$375,560
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Grimster, Neil P; Connelly, Stephen; Baranczak, Aleksandra et al. (2013) Aromatic sulfonyl fluorides covalently kinetically stabilize transthyretin to prevent amyloidogenesis while affording a fluorescent conjugate. J Am Chem Soc 135:5656-68
Bulawa, Christine E; Connelly, Stephen; Devit, Michael et al. (2012) Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A 109:9629-34
Witherden, Deborah A; Watanabe, Megumi; Garijo, Olivia et al. (2012) The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal ?? T cell function. Immunity 37:314-25
Kasmar, Anne G; van Rhijn, Ildiko; Cheng, Tan-Yun et al. (2011) CD1b tetramers bind ?? T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J Exp Med 208:1741-7
Verdino, Petra; Witherden, Deborah A; Podshivalova, Katie et al. (2011) cDNA sequence and Fab crystal structure of HL4E10, a hamster IgG lambda light chain antibody stimulatory for ?? T cells. PLoS One 6:e19828
Kirchdoerfer, Robert N; Garner, Amanda L; Flack, Caralyn E et al. (2011) Structural basis for ligand recognition and discrimination of a quorum-quenching antibody. J Biol Chem 286:17351-8
Verdino, Petra; Witherden, Deborah A; Ferguson, M Sharon et al. (2011) Molecular insights into ?? T cell costimulation by an anti-JAML antibody. Structure 19:80-9
Witherden, Deborah A; Verdino, Petra; Rieder, Stephanie E et al. (2010) The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation. Science 329:1205-10
Verdino, Petra; Witherden, Deborah A; Havran, Wendy L et al. (2010) The molecular interaction of CAR and JAML recruits the central cell signal transducer PI3K. Science 329:1210-4
Yoshida, Kenji; Corper, Adam L; Herro, Rana et al. (2010) The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity. J Clin Invest 120:1578-90

Showing the most recent 10 out of 88 publications